ascent: sacituzumab govitecan outperforms chemo in black patients with tnbc
Published 2 years ago • 370 plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
4:25
ascent: sacituzumab govitecan shows promise in mtnbc patients
-
3:05
esmo 2020 highlights on sacituzumab govitecan in metastatic tnbc: the ascent study
-
1:58
ascent-04: sacituzumab govitecan and pembrolizumab in pd-l1-positive tnbc
-
3:10
ascent trial: sacituzumab govitecan for tnbc
-
2:15
ascent: sacituzumab govitecan biomarker analysis
-
1:49
final os analysis of sacituzumab govitecan in tropics-02
-
3:31
the ascent of sacituzumab govitecan in metastatic tnbc | aditya bardia
-
2:16
efficacy of sacituzumab govitecan by trop-2 expression in patients with muc
-
2:57
efficacy of sacituzumab govitecan in muc by trop-2 expression
-
1:36
real-word efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer
-
0:46
oncotarget: sacituzumab govitecan in triple-negative breast cancer
-
5:16
study of sacituzumab govitecan for triple-negative breast cancer
-
5:01
sacituzumab govitecan in patients with previously treated muc
-
1:13
phase iii tropics-04 trial: sacituzumab govitecan vs treatment of choice in advanced muc
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
3:54
biomarker analysis: sacituzumab govitecan vs chemotherapy in metastatic tpn breast cancer
-
3:47
sacituzumab govitecan in mtnbc
-
2:58
#esmo22 highlights on sacituzumab govitecan in hr /her2- metastatic breast cancer: tropics-02